{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-073787","form_type":"8-K","ticker":null,"cik":"0001567892","company_name":"Keenova Therapeutics plc","filed_at":"2026-06-15T12:00:39+00:00","discovered_at":"2026-06-15T12:05:16.426500+00:00","generated_at":"2026-06-15T12:07:23.957947+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Keenova Therapeutics to sell Percocet and Endocet businesses to Par Health for up to $250M","bullets":["Upfront purchase price $25M; quarterly earnout payments over 5 years based on gross profit of the Business.","Transaction expected to close in Q3 2026, subject to HSR clearance and other customary closing conditions.","After closing, Keenova will no longer market, manufacture, or distribute opioid products.","Consideration total up to ~$250M; deal includes Percocet and Endocet businesses sold to Par Health, Inc."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-073787","json":"https://secwatch.observer/filing/0001104659-26-073787.json","markdown":"https://secwatch.observer/filing/0001104659-26-073787.md","text":"https://secwatch.observer/filing/0001104659-26-073787.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926073787/0001104659-26-073787-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1567892/000110465926073787/tm2617927d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T12:07:23.957947+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}